Skip to content
FrontierPicks

Covered

NAVN · Navan

Conviction · Low · more likely to lag the S&P 500 over the next three months

Wrong if: a daily close above $33.26

Note written ·

Price against the kill line

23.6% clear of its kill line on the 13 November 2026 close.

How to read this

This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

NAVNNavan
$33.26
$25.42
23.6%well clear

Three months against the kill line

NAVN daily closes from 17 August 2026 to 13 November 2026, last $25.42, against its kill line: a daily close above $33.26. 17 August 2026: $28.7218 August 2026: $29.2019 August 2026: $29.1820 August 2026: $28.5621 August 2026: $29.1624 August 2026: $29.3625 August 2026: $29.2926 August 2026: $29.3327 August 2026: $30.5828 August 2026: $28.5031 August 2026: $29.061 September 2026: $27.312 September 2026: $26.903 September 2026: $27.714 September 2026: $27.788 September 2026: $26.649 September 2026: $25.8910 September 2026: $20.2611 September 2026: $21.0214 September 2026: $21.3715 September 2026: $22.4216 September 2026: $22.5317 September 2026: $22.1318 September 2026: $21.3621 September 2026: $21.5322 September 2026: $20.9723 September 2026: $19.6624 September 2026: $19.4325 September 2026: $19.4228 September 2026: $19.9829 September 2026: $20.6930 September 2026: $20.991 October 2026: $21.502 October 2026: $21.435 October 2026: $21.846 October 2026: $21.347 October 2026: $22.288 October 2026: $23.089 October 2026: $23.6412 October 2026: $23.5613 October 2026: $23.9014 October 2026: $24.0015 October 2026: $25.2016 October 2026: $25.3819 October 2026: $25.6720 October 2026: $26.2821 October 2026: $26.6222 October 2026: $26.0323 October 2026: $26.9626 October 2026: $27.2027 October 2026: $27.0828 October 2026: $27.0029 October 2026: $26.6330 October 2026: $26.102 November 2026: $25.383 November 2026: $24.804 November 2026: $27.065 November 2026: $25.426 November 2026: $25.489 November 2026: $26.0810 November 2026: $24.6811 November 2026: $26.4012 November 2026: $26.2013 November 2026: $25.42

Daily closes, to . Red: the kill line, a daily close above $33.26, on record since 11 November 2026. The shares are down 11.5% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close above $33.26, over the $30.88 52-week high, which would show the shares leading the market. A fiscal 2027 revenue outlook raised above the $927–933 million range would point the same way.

Research onlyNot in the portfolio.

The portfolio's record →

Key figures from the filings · Technology

Quarter to 31 July 2026, filed 10 September 2026; valuation at the 13 November 2026 close

Revenue, latest quarter ($M)
233
Revenue, change on a year (%)
+35.4
Gross margin (%)
74.1
Operating margin (%)
−11.0
Free cash flow, four quarters ($M)
45.5
Net cash, cash less debt ($M)
819
Enterprise value to sales (×)
6.9
Free-cash-flow yield (%)
0.7
All filed numbers

What Navan reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 233 +35.4 74.1 −11.0
first filed 220 +39.9 74.0 −8.2
first filed 178 +34.8 70.7 −50.3
first filed 195 +29.0 70.7 −40.6
first filed 172 — 72.7 −7.1
first filed 158 — 71.0 −10.1
Income Quarter to 31 July 2026, filed 10 September 2026
Pre-tax income ($M) −26.3
Net income ($M) four quarters: −348 −29.1
Diluted shares, change on a year (%) against the quarter to 31 July 2025 +450.8
Cash flow Four quarters to 31 July 2026, filed 10 September 2026
Operating cash flow ($M) 47.3
Capital spending ($M) 1.8
Free cash flow ($M) 45.5
Balance sheet At 31 July 2026, filed 10 September 2026
Cash and short-term investments ($M) 820
Debt ($M) notes 0.9
Net cash, cash less debt ($M) 819
Deferred revenue ($M) 45.7
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) 213
Inventory ($M) Not reported
Shareholders' equity ($M) 1,316
Valuation At the 13 November 2026 close, filed figures to 10 September 2026
Market value ($M) 6,517
Enterprise value, market value plus net debt ($M) 5,698
Enterprise value to sales (×) 6.9
Enterprise value to operating income (×) Not meaningful
Price to earnings (×) Not meaningful
Price to book value (×) 5.0
Free-cash-flow yield (%) 0.7

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 5.0% of shares outstanding sold short, 5.0 days of average trading to cover, +8.8% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $14.1M
12 monthsfrom $45.3M $69.2M

The thesis

Navan's shares are more likely to lag the S&P 500 than lead it over the next three months. They closed at $26.20 on 12 November 2026, 15.2% under the 52-week high, with no new financial results since the 9 September 2026 guidance raise and with insiders still selling. The fiscal third-quarter report, guided to $253–255 million of revenue and expected around 15 December 2026, settles the call.

The market has priced in most of the good news. The shares sit above the $25 IPO price and well above the 200-day average, and MarketBeat's average analyst target of $29.43 (9 November 2026, 17 analysts) sits above the close. The September beat-and-raise did not hold the shares up, and the October and November customer announcements have moved them within a narrow range.

Three customer headlines arrived in four weeks: Investec (12 October 2026), Ingersoll Rand (3 November 2026) and Wise (10 November 2026). Each is a company announcement with undisclosed terms. The shares closed at $25.42 on 5 November 2026, $24.68 on 10 November 2026 and $26.20 on 12 November 2026. That is a six-session range of about $1.70, with no break in either direction.

Bullish and bearish views on Navan, Inc.

The bull case on Navan, Inc. (NAVN), in brief: growth accelerated in the last report. The bear case: the market sold the last beat-and-raise.

Bull case

  • Growth accelerated in the last report. Fiscal second-quarter 2027 revenue was $233 million, up 35% from a year earlier. Gross booking volume was $3.0 billion, up 45%, and non-GAAP operating margin was 7% (investor presentation, 9 September 2026).
  • Guidance was raised. Fiscal 2027 revenue guidance moved from $907–913 million to $927–933 million, and non-GAAP operating income guidance from $76–80 million to $82–86 million (results release, 9 September 2026).
  • Enterprise wins keep arriving. Investec (12 October 2026), Ingersoll Rand (3 November 2026) and Wise (10 November 2026) each named Navan for corporate travel programs (company news, Benzinga). None disclosed contract terms.
  • AI positioning has a named partner. Navan said on 16 October 2026 that several of its production AI travel agents run on Nvidia Nemotron 3.5 Super VL (Benzinga). That supports valuing it as software rather than a travel agency.
  • The shares trade above both major averages. The 12 November 2026 close of $26.20 is above the 50-day average of $23.92 and the 200-day average of $19.98 (adjusted daily closes). The 52-week closing low was $8.51 on 24 March 2026.

Bear case

  • The market sold the last beat-and-raise. Benzinga reported the shares down 17% premarket on 10 September 2026, the morning after the report. The close was $29.25 on 14 August 2026 against $26.20 on 12 November 2026, a 10.5% decline over three months.
  • Insiders keep selling. Chief executive Ariel Cohen sold 393,378 shares at $30.14 on 27 August 2026, 50,647 at $21.27 on 21 September 2026, and 8,033 at $26.13 on 2 November 2026 under a Rule 10b5-1 plan (SEC Form 4). President Michael Sindicich sold 8,977 and chief technology officer Ilan Ezra Twig sold 36,040 on 21 September 2026 (SEC Form 4).
  • IPO litigation remains open. A securities class action filed in February 2026 alleges the IPO documents omitted rising sales and marketing costs (Berger Montague). Kahn Swick & Foti announced an investigation of officers and directors on 16 October 2026.
  • GAAP losses remain large. In the year-ago third quarter, Navan reported a net loss of $225 million on $195 million of revenue (CFO Dive, 16 December 2025). The profit case rests on the adjusted measure.
  • The third quarter requires a margin step-up. Guidance of $35.5–36.5 million of non-GAAP operating income on $253–255 million of revenue implies a margin of roughly 14%, while BoomPop and Smartrips are integrated (results release, 9 September 2026).

Price setup

The shares closed at $26.20 on 12 November 2026. The 52-week intraday high is $30.88, set on 27 August 2026; the last close is 15.2% below it. The 3-month change is negative 10.5%.

The 50-day average is $23.92 and the 200-day average is $19.98, both as of the 12 November 2026 close. The $25 IPO price is the nearest round reference. The shares closed under it once in the last six sessions, at $24.68 on 10 November 2026, and recovered to $26.40 on 11 November 2026.

The fiscal quarter ended 31 October 2026. The report date has not been announced, and last year's third-quarter report came on 15 December 2025. Event risk therefore sits ahead in mid-December.

Catalysts ahead

  • ~25 November 2026 (est.): Announcement of the fiscal third-quarter 2027 report date and call details. Fixes the date of the event that tests the shares; the second-quarter date was announced about two weeks ahead.
  • ~15 December 2026 (est.): Fiscal third-quarter 2027 results, for the quarter ended 31 October 2026. Shows whether revenue against the $253–255 million guide, the margin step-up and the $927–933 million full-year range support the current price after two acquisitions.

What would change the view

A daily close above $33.26, over the $30.88 52-week high, which would show the shares leading the market. A fiscal 2027 revenue outlook raised above the $927–933 million range would point the same way.

What it trades with

Navan trades on its own company news, insider filings and IPO litigation more than on any peer group. The September decline followed its own report, and the October and November moves followed customer announcements.

Corporate travel volume ties it to airline and hotel demand, and the AI-agent angle ties it to enterprise-software sentiment. The post-IPO trading history is too short to measure either link.

The evidence, claim by claim (8)
  1. Fiscal second-quarter 2027 revenue was $233 million, up 35% from a year earlier; gross booking volume was $3.0 billion, up 45%; non-GAAP operating margin was 7%. Navan fiscal second-quarter 2027 investor presentation · as of
  2. Fiscal 2027 guidance raised to revenue of $927–933 million and non-GAAP operating income of $82–86 million, from $907–913 million and $76–80 million. Navan fiscal second-quarter 2027 results release · as of
  3. Fiscal third-quarter 2027 guidance: revenue of $253–255 million and non-GAAP operating income of $35.5–36.5 million. Navan fiscal second-quarter 2027 results release · as of
  4. Wise selected Navan for corporate travel management; terms not disclosed. Company news · as of
  5. Ingersoll Rand selected Navan to supply a global travel management program; terms not disclosed. Company news · as of
  6. Chief executive Ariel Cohen sold 8,033 shares at $26.13 on 2 November 2026 under a Rule 10b5-1 plan. SEC Form 4 filed 3 November 2026 · as of
  7. Cohen sold 393,378 shares at $30.14 on 27 August 2026, the day of the 52-week high, under a Rule 10b5-1 plan. SEC Form 4 filed 31 August 2026 · as of
  8. Average analyst target $29.43 from 17 analysts; high $38, low $23. MarketBeat forecast page · as of

Sources

Related · shared themes

See also · stocks to watch

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X